Information  X 
Enter a valid email address
  Print          More announcements

Friday 11 June, 2021

JPMorgan Sec.Plc

UDG Healthcare Plc 38.5a amend

RNS Number : 7032B
JPMorgan Securities Plc
11 June 2021
 

Ap24

 

  AMENDMENT

FORM   38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

J.P. Morgan Securities Plc

Companydealtin

UDG Healthcare Plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

€0.05 ordinary shares

Date of dealing

24 May 2021

 

2.  DEALINGS  (Note   2)

 

(a)  Purchases and sales

 

Total numberofrelevantsecuritiesacquired

Highestpricepaid (Note 3)

Lowest price paid

(Note 3)

654,047

10.7040 GBP

10.4400 GBP

 

 

Total numberofsecuritiesdisposed

Highestpricereceived (Note 3)

Lowestpricereceived

(Note 3)

706,905

10.7700 GBP

10.4500 GBP

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 4)

Numberofrelevantsecurities

(Note 5)

Priceperunit

(Note 3)

Equity Swap

Decrease Long

 

 

 

 

Decrease Short

 

 

 

 

 

 

Increase Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase Short

 

 

 

 

 

 

Opening a Long Position

 

Opening a Short Position

72

26,870

22

5,907

 

270,000

11,850

38,830

1,498

2,385

56,864

 

211

1,501

361

7,713

14,827

5,221

932

548

2,051

7,216

691

1,471

106

447

26

 

330

250,000

2,245

20,635

920

11,152

 

30,000

 

20,000

10.4701 GBP

10.6700 GBP

10.6701 GBP

10.6755 GBP

 

10.5426 GBP

10.5545 GBP

10.6536 GBP

10.6626 GBP

10.6680 GBP

10.6762 GBP

 

10.5002 GBP

10.5097 GBP

10.5299 GBP

10.5917 GBP

10.6155 GBP

10.6338 GBP

10.6448 GBP

10.6497 GBP

10.6652 GBP

10.6695 GBP

10.6698 GBP

10.6700 GBP

10.6900 GBP

10.6990 GBP

10.7000 GBP

 

10.4861 GBP

10.5079 GBP

10.5428 GBP

10.5968 GBP

10.6700 GBP

10.7040 GBP

 

10.6818 GBP

 

10.6483 GBP

 

Ap25

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

e.g. call option

Writing, selling, purchasing, varyingetc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, Europeanetc.

Expiry date

Option money paid/received perunit (Note 3)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 3)

 

 

 

 

 

3.   OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any   other   person   relating   to   the   voting   rights   of   any   relevant   securities   under   any   option   referred   to  

on   this   form   or   relating   to   the   voting   rights  or future acquisition or disposal of any relevant securities 

to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

Dateofdisclosure

11  June 2021

Contactname

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

UDG Healthcare Plc

Nature of connection (Note 6)

Financial adviser to CD&R Fund XI

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEBLGDLXGBDGBB

a d v e r t i s e m e n t